Nicholaou, Theo <br/><br/>
Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2009 
 - 2166-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-08-2484  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, Neoplasm--administration & dosage<br/>Cancer Vaccines--administration & dosage<br/>Cholesterol--administration & dosage<br/>Drug Combinations<br/>Female<br/>Humans<br/>Hypersensitivity, Delayed--etiology<br/>Male<br/>Melanoma--therapy<br/>Membrane Proteins--administration & dosage<br/>Middle Aged<br/>Phospholipids--administration & dosage<br/>Saponins--administration & dosage<br/>T-Lymphocytes--immunology<br/>T-Lymphocytes, Regulatory--physiology<br/>Vaccination